Alpha-GPC vs CDP-Choline
The table compares the compounds’ key data from their entry pages. Open each compound’s full entry for details. Educational content, not medical advice.
| AAlpha-GPC | CCDP-Choline | |
|---|---|---|
| What it is | A choline source that the body turns into acetylcholine, one of the brain's messenger chemicals. | Citicoline: a supplement that supplies choline and uridine for building brain cells; prescription-only in some countries. |
| MechanismMechanism of actionThe molecular pathway by which a compound acts in the body (e.g. which receptor or enzyme it binds). | Choline precursor (ACh synthesis) | Choline + uridine precursor |
| Half-lifeHalf-lifeThe time for the compound’s plasma concentration to fall by half; indicates how fast it clears and how often it is dosed. | ~4-6 h | ~56 h (two phases) |
| Legal statusLegal / WADA statusThe compound’s regulatory status (e.g. prescription) and its place on the WADA prohibited-in-sport list. | EU Rx (IT) / OTC elsewhere | EU Rx / USA OTC |
| Full entry | Open → | Open → |
Alpha-GPC or CDP-choline: what is the difference?
Both are choline sources: the body breaks them down into choline, which is turned into acetylcholine, one of the brain's messenger chemicals. Their other breakdown product differs: Alpha-GPC yields glycerophosphate, a building block of cell membranes, while CDP-choline (citicoline) yields uridine, which according to its entry supports the growth of connections between nerve cells. According to their entries Alpha-GPC quickly raises choline levels and has a half-life of about 4-6 hours, while CDP-choline's is about 56 hours, in two phases. Their status is similar: Alpha-GPC is a prescription medicine in Italy (Delecit) for dementia of vascular origin, CDP-choline is prescription-only in Italy, Spain and Japan; in the United States both are dietary supplements, and in Hungary both are freely available.